Performance Combined With Natural Fuels Botaneco Launch

    Canadian Biotech SemBioSys Enters Skincare Market with Dedicated Business

    CALGARY, ALBERTA, August 20 /CNW/ - The way in which many cosmetics and
personal care items are developed is about to change, thanks to the creation
of a newly formed, dedicated business unit from Canadian based biotechnology
company SemBioSys (TSX VENTURE:SBS), called Botaneco.

    The Botaneco business unit will manufacture and market branded lines of
high performance, naturally derived base emulsions and delivery systems used
in the development of cosmetics, personal care and prescription
topical/dermatology products. Botaneco will leverage SemBioSys' proprietary
technology, a first in class system that harnesses the naturally occurring and
multifunctional benefits of seed oilbodies, to offer a smart alternative to
current industry mainstays such as petroleum and other chemically derived

    "The Botaneco business unit gives SemBioSys increased control over its
commercial activities targeting the multi-billion dollar personal care and
dermatology marketplace, and offers SemBioSys a focused organization with all
the resources to make this launch successful for our customers and our
stakeholders," SemBioSys president and CEO Andrew Baum says. "The launch of
Botaneco represents another milestone in the implementation of our overall
strategy in which our non-pharmaceutical products generate revenues in the
short term, while longer term revenues are derived from our pharmaceutical

    Being natural no longer means sacrificing performance, according to
Botaneco managing director Nancy Markley, Ph.D. The first Botaneco branded
product utilizing the SemBioSys technology is slated to be launched in the
fourth quarter of 2007. This natural, oil body based emulsion provides an all
in one system for emulsification, and delivers superior hydration, skin
barrier protection and absorption of nutrient rich moisturizers and emollients
as well as enhanced performance of skincare actives.

    Markley adds that Botaneco is currently embarking on an educational
campaign to inform consumers and business partners of the smart benefits of
going green with Botaneco - economically and ecologically.

    About Botaneco

    From development through delivery, Botaneco is a performance based,
technologically advanced botanical science organization that manufactures and
markets a branded line of products that harness the naturally occurring
benefits of protein protected seed oils. Botaneco provides performance,
innovation and choice in creating natural, renewable and versatile delivery
systems and ingredients used in the development of cosmetics, personal care
and prescription topical/dermatology products beneficial to humans and the
environment. More information can be accessed at

    About SemBioSys

    With headquarters in Calgary, Alberta, SemBioSys Genetics Inc. is a
biotechnology company developing protein-based pharmaceuticals for metabolic
and cardiovascular diseases. The Company's lead pharmaceutical candidates are
recombinant human insulin to serve the rapidly expanding global diabetes
market and Apo AI, a next generation cardiovascular drug. In addition to its
pharmaceutical products, SemBioSys is developing a series of
non-pharmaceutical products addressing animal and aquaculture health,
nutritional oils and human topical markets. More information is available and
can be accessed at

    This press release contains certain forward-looking statements,
including, without limitation, statements containing the words "believe",
"may", "plan", "will", "estimate", "continue", "anticipate", "intend",
"expect" and other similar expressions which constitute "forward-looking
information" within the meaning of applicable Canadian securities laws.
Forward-looking statements reflect the Company's current expectation and
assumptions, and are subject to a number of risks and uncertainties that could
cause actual results to differ materially from those anticipated. These
forward-looking statements involve risks and uncertainties including, but not
limited to, changing market conditions, the successful and timely completion
of clinical studies, the establishment of corporate alliances, the impact of
competitive products and pricing, new product development, uncertainties
related to the regulatory approval process and other risks detailed from
time-to-time in the Company's ongoing filings with the Canadian securities
regulatory authorities which filings can be found at Given
these risks and uncertainties, readers are cautioned not to place undue
reliance on such forward-looking statements. The Company undertakes no
obligation to publicly update or revise any forward-looking statements either
as a result of new information, future events or otherwise, except as required
by applicable Canadian securities laws.

For further information:

For further information: SemBioSys Genetics Inc. Mr. Andrew Baum,
President and Chief Executive Officer, 403-717-8767 Fax: 403-250-3886 E-mail: Internet: or Botaneco Nancy Markley,
Ph.D., Managing Director, 403-717-8774 Fax: 403-250-3886 Email: Internet:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890